
Reaching for Returns, and Risk: Researching Micro-cap Companies
Welcome to the August 2026 edition of our newsletter! In this issue, we’ll examine how fraudsters use micro-cap and small-cap stock offerings to defraud investors looking for outsized returns, and highlight steps that your clients can take to avoid being a victim.
Micro Cap, Big Dreams: The Risks of Investing “Over the Counter”
Many investors, especially retail day traders, like to swing for the fences, trying to predict “the next big thing” before larger investors see what’s coming. This spirit pushes capital into newer, often underfunded, innovations and the companies which pursue them. Yet it also makes hopeful, hungry investors a target for “pump and dump” fraud.
These schemes are nothing new: for several generations, stock promoters and incredulous company executives have promised both life-changing technologies, especially in biotechnology and other cutting-edge life sciences, and returns that could also be game-changing. These schemes took on new life in the late 1990s, as the prevalence of online bulletin boards – and, later, both social media and finance related message boards — made it easier for schemers to both spread their overly enthusiastic claims about companies in which they had invested, but also to know that their target audience was naturally drawn to such places, looking for investing ideas as eagerly as the schemers were ready to provide them. Once the buying frenzy reaches its peak and drives valuations well above what fundamentals would justify, the perpetrators head for the exits, leaving the retail investors holding steep losses.
Enforcement Agencies Go After Easier Targets, but Risks Remain
In July 2026, the U.S. Securities and Exchange Commission reportedly ramped up efforts to police, and possibly eradicate, one part of this global scheme: international networks of “micro-cap” promoters in Asia, pushing everything from online travel agencies to restaurant chains, saw their listings of newly public U.S. offerings plummet from 2025 through the end of June in 2026, largely due to increased regulatory scrutiny.
Your clients, seeking to gain access to new ideas and greater returns, can be their own watchdog, scrutinizing the backgrounds of company leadership, especially in highly technical fields such as life sciences, to ascertain whether they have the capability to truly bring their ideas to market. The viability of the company and its products are equally important, and can be determined by looking at corporate filings – and any gaps in filing, large scale and rapid management changes, or other red flags – as well as litigation histories and publicly available records of debt accumulation, which included in offering statements and are often a topic of business media interest.
Innovative technologies can pay off for everyone involved, but only if those driving across the new frontier are acting in good faith and taking appropriate actions to bring their innovations to market.